• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nucleosides Nucleotides Nucleic Acids . Genomic determinants in pathogenicity of SARS-CoV-2 versa common cold coronaviruses

tetano

Editor, Senior Moderator
Nucleosides Nucleotides Nucleic Acids


. 2024 Nov 21:1-13.
doi: 10.1080/15257770.2024.2430397. Online ahead of print. Genomic determinants in pathogenicity of SARS-CoV-2 versa common cold coronaviruses

Zahra Arab-Bafrani[SUP] 1 2 [/SUP], Majid Nikoubin-Boroujeni[SUP] 1 [/SUP], Saeedeh Ebrahimi[SUP] 3 4 [/SUP], Ali Teimoori[SUP] 5 [/SUP], Elham Heidari[SUP] 6 [/SUP], Elham Mousavi[SUP] 3 4 [/SUP]



Affiliations
Abstract

Determination of the different short oligonucleotide features in the full genome of fatal and mild coronavirus strains can show the researchers how these viruses evolved and became virulent strains. To this aim, at first, in the full genome of all coronavirus strains included in this study, the observed and expected frequency of dinucleotide to hexanucleotide was obtained using Markov method. Then odds ratio (observed/expected abundances) of short oligonucleotide was computed and considered as the raw data (features). Finally, ten distinct weighting algorithms approaches (Information Gain, Information Gain Ratio, Rule, Deviation, Chi Squared, Gini Index, Uncertainty, Relief, Support Vector Machine (SVM), and PCA) was employed on the features to identify oligonucleotide distribution differences across the full genome of SARS-related viruses compared to common cold coronaviruses. Totally among 5440 features (16 dinucleotides, 64 trinucleotides, 256 tetra nucleotides, 1024 penta-nucleotides, and 4096 Hexa-nucleotides), CC, CCA, CCAC, ACCAC, and CACCAC motifs were selected by 80 -90% of all weighting algorithms models to distinguish virulent strains from mild coronaviruses. These remarkable oligonucleotides might point toward the existence of some particular RNA elements that might be involved in viral virulence and thus can be targeted for viral treatment in the future.

Keywords: MERS; SARS; SARS-CoV-2; common cold coronaviruses; oligonucleotide patterns.

 
Back
Top Bottom